Clinical Trials Directory

Trials / Completed

CompletedNCT06456216

Performance Evaluation of Diagnostic Accuracy of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population and in Cancer Free Population.

Performance Evaluation of Diagnostic Accuracy (Sensitivity and Specificity) of PanTum Detect Test for Detection of Solid Tumours in Known Cancer Population (Sick Population) and in Cancer Free (Healthy) Population.

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Max Healthcare Insititute Limited · Academic / Other
Sex
All
Age
30 Years – 75 Years
Healthy volunteers
Accepted

Summary

Performance evaluation of diagnostic accuracy (Sensitivity and Specificity) of PanTum detect Test for detection of solid tumours in known cancer population (Sick population) and in cancer free (Healthy) population.

Detailed description

PanTum Detect is a simple blood test that can detect presence of solid tumors using two important tumor biomarkers - Apo 10 and TKTL-1. Most tumors develop slowly and gradually. From the first tumor cell, to the identification of the tumor itself, there can be a timespan of many years. The turning point where a locally growing tumor develops into an invasive, metastasizing cancer is paramount for curability. It is the objective of PanTum Detect to detect a tumor in time before this critical turning point. Such locally growing tumors can often easily be removed by surgery or treated successfully

Conditions

Timeline

Start date
2022-02-21
Primary completion
2022-11-14
Completion
2023-10-20
First posted
2024-06-13
Last updated
2024-06-13

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT06456216. Inclusion in this directory is not an endorsement.